Article: Other News To Note.

Accelrys Inc., of San Diego, a wholly owned subsidiary of Pharmacopeia Inc., of Princeton, N.J., and Personal Chemistry AB, of Uppsala, Sweden, entered a software licensing agreement and technology alliance. Accelrys will license the use of and provide integration support for Accord for Oracle and Accord Chemistry Control, an active X -based control that will be integrated into Coherent Synthesis to provide chemical computational and data management functions. Coherent Synthesis incorporates chemistry methodology, software, automation, microwave technology and reagents to speed up chemical reactions by between 10 and 1,000 times, often with an increased yield of the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!